Doctors say it's increasingly common for adults who've never had allergies to suddenly experience symptoms like sneezing, ...

Spring is the season of growth, and as Michiganders say goodbye to snow, pollen is the next visitor. Here's more on the ...

Pollen counts are expected to soar in the Pacific Northwest on Thursday and Friday, causing symptoms such as itchy eyes, ...

Staying indoors when pollen levels are high – or on dry, windy days, can help reduce sneezing and congestion. So can various ...

Native live oaks may provide hardy shade during the long hot summer ahead, but they cause a lot of misery before then. Live oak trees explode with lime green pollen from March through early May, ...

Sanofi and Regeneron’s Dupixent (dupilumab) has been approved by the US Food and Drug Administration (FDA) for chronic ...

Eight UK cities have seen their average hay fever season extended by 29 days a year as a result of climate change ...

The FDA has approved the popular drug Dupixent (generic name, dupilumab) for adults and kids 12 and up with chronic spontaneous urticaria (CSU), a long-lasting itchy skin condition, when regular ...

Biotech giant Regeneron Pharmaceuticals, Inc. REGN is slated to report first-quarter 2025 results on April 29, 2025. The ...

Spring is finally here, and for many of us that brings the joy of returning to outdoor activities, planning summer vacations, and … well, allergies. Depending on the allergen, people ...

The FDA has approved Dupixent for the treatment of patients aged 12 years and older with CSU who remain symptomatic despite H1 antihistamine treatment.

SaveHealth takes a peek into America's medicine cabinets to understand what families are stocking, why they're stocking it, ...